Big Pharma Once Again Makes Billions Off Of A Drug That Doesn’t Work

When the government suddenly announces a recall, or even talks about pulling a product from the shelves, it’s normal to assume that some unexpected defect has recently been discovered. Maybe the feds have noticed that a car’s airbags don’t deploy during a crash, or that a certain brand of fish tank is prone to spontaneous implosion. Whatever the case, you’re inclined to think that some new information has come to light that necessitates the recall. And in most circumstances that’s true.

But there is one industry —Big Pharma — that has consistently been the exception to this rule. This is an industry that happens to enjoy a lot of special treatment from the federal government, including immunity from lawsuits. In the pharmaceutical industry, a recall doesn’t necessarily mean that some catastrophic defect has just been identified. Instead, it often means that there’s been a known problem for a very long time — one that’s been deliberately hidden from the public, until finally it’s impossible to deny any longer. After COVID, most of the country realizes that this kind of thing can happen. What they might not realize, because there’s a mountain of propaganda designed to hide this fact, is how common this is.